Monthly Dosage and Treatment Guidelines for Talazoparib/talazopanib

The dosage regimen of Talazoparib is designed based on its pharmacokinetic characteristics and tolerability assessment, aiming to maximize efficacy while minimizing adverse reactions. For adult breast cancer patients, the recommended dose is 1 mg, taken orally once a day before or after a meal. Maintaining a stable blood concentration is particularly important for the efficacy of the drug. For prostate cancer patients treated in combination with enzalutamide, the recommended dose is 0.5 mg once daily. The reason is that combination therapy may increase the risk of hematological adverse reactions, so appropriately reducing the dose can improve tolerance.

The current common specification on the market is 1mg*30 capsules. According to the recommended dose for breast cancer, it is exactly 1 box per month; for prostate cancer patients, the 0.5mg dose means that one box of 1mg preparation can be divided into two months. Of course, you need to follow the doctor's prescription when taking the specific medication. Especially when adverse reactions such as thrombocytopenia, anemia, and neutropenia occur, treatment may need to be suspended or reduced. Overseas guidelines suggest that when grade ≥3 hematological toxicity occurs, the dose can be adjusted to 0.75 mg or 0.5 mg once daily, or even reduced to 0.25 mg when necessary, to balance efficacy and safety.

In terms of treatment duration, talazoparib is a long-term oral maintenance treatment drug. As long as the patient benefits from it and tolerates it well, the drug will generally continue until the disease progresses or the toxicity becomes intolerable. Some patients can see a reduction in tumor burden after several months of use, but complete discontinuation should be evaluated with caution because disease may relapse. In combination therapy for prostate cancer, the course of talazoparib is usually synchronized with enzalutamide to maintain long-term inhibition of tumor cell proliferation.

In the Chinese market, since1mg is the main dosage form, some hospitals have been equipped with 0.25mg or 0.5mg capsules to facilitate dosage adjustment and reduce the inconvenience of patients dispensing medicines by themselves. For imported original drugs, the supply is relatively stable, but the price is still high. Some patients choose to purchase drugs overseas or obtain drugs through patient assistance programs.

Reference materials:https://www.talzenna.com/